Vested-interest medical cannabis trial to target 20,000 people

Drug Science – chaired by legaliser David Nutt – claims that Project Twenty21 will “create” evidence on medical cannabis. At least 3 cannabis manufacturers/ distributors are involved, along with a ‘patient’ cannabis advocacy cofounded by David Nutt.